@article{Jongeneel2022,
abstract = {Genomics policy development involves assessing a wide range of issues extending from specimen collection and data sharing to whether and how to utilize advanced technologies in clinical practice and public health initiatives. A survey was conducted among African scientists and stakeholders with an interest in genomic medicine, seeking to evaluate: 1) Their knowledge and understanding of the field. 2) The institutional environment and infrastructure available to them. 3) The state and awareness of the field in their country. 4) Their perception of potential barriers to implementation of precision medicine. We discuss how the information gathered in the survey could instruct the policies of African institutions seeking to implement precision, and more specifically, genomic medicine approaches in their health care systems in the following areas: 1) Prioritization of infrastructures. 2) Need for translational research. 3) Information dissemination to potential users. 4) Training programs for specialized personnel. 5) Engaging political stakeholders and the public. A checklist with key requirements to assess readiness for implementation of genomic medicine programs is provided to guide the process from scientific discovery to clinical application.},
author = {Jongeneel, C Victor and Kotze, Maritha J and Bhaw-Luximon, Archana and Fadlelmola, Faisal M and Fakim, Yasmina J and Hamdi, Yosr and Kassim, Samar Kamal and Kumuthini, Judit and Nembaware, Victoria and Radouani, Fouzia and Tiffin, Nicki and Mulder, Nicola},
doi = {10.3389/fgene.2022.769919},
file = {:C$\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Jongeneel et al. - 2022 - A view on genomic medicine activities in Africa implications for policy.pdf:pdf},
issn = {1664-8021},
journal = {Frontiers in Genetics},
keywords = {Africa,OA,Personalized genomic medicine,Readiness level,Translational research,capacity development,fund{\_}ack,infrastructure,original,precision medicine stakeholders},
mendeley-tags = {OA,fund{\_}ack,original},
month = {apr},
pages = {769919},
pmid = {35571023},
publisher = {Frontiers},
title = {{A view on genomic medicine activities in Africa: implications for policy}},
url = {https://www.frontiersin.org/articles/10.3389/fgene.2022.769919/full},
volume = {13},
year = {2022}
}

{"_id":"BbLjW4WA64syZ2dgf","bibbaseid":"jongeneel-kotze-bhawluximon-fadlelmola-fakim-hamdi-kassim-kumuthini-etal-aviewongenomicmedicineactivitiesinafricaimplicationsforpolicy-2022","author_short":["Jongeneel, C V.","Kotze, M. J","Bhaw-Luximon, A.","Fadlelmola, F. M","Fakim, Y. J","Hamdi, Y.","Kassim, S. K.","Kumuthini, J.","Nembaware, V.","Radouani, F.","Tiffin, N.","Mulder, N."],"bibdata":{"bibtype":"article","type":"article","abstract":"Genomics policy development involves assessing a wide range of issues extending from specimen collection and data sharing to whether and how to utilize advanced technologies in clinical practice and public health initiatives. A survey was conducted among African scientists and stakeholders with an interest in genomic medicine, seeking to evaluate: 1) Their knowledge and understanding of the field. 2) The institutional environment and infrastructure available to them. 3) The state and awareness of the field in their country. 4) Their perception of potential barriers to implementation of precision medicine. We discuss how the information gathered in the survey could instruct the policies of African institutions seeking to implement precision, and more specifically, genomic medicine approaches in their health care systems in the following areas: 1) Prioritization of infrastructures. 2) Need for translational research. 3) Information dissemination to potential users. 4) Training programs for specialized personnel. 5) Engaging political stakeholders and the public. A checklist with key requirements to assess readiness for implementation of genomic medicine programs is provided to guide the process from scientific discovery to clinical application.","author":[{"propositions":[],"lastnames":["Jongeneel"],"firstnames":["C","Victor"],"suffixes":[]},{"propositions":[],"lastnames":["Kotze"],"firstnames":["Maritha","J"],"suffixes":[]},{"propositions":[],"lastnames":["Bhaw-Luximon"],"firstnames":["Archana"],"suffixes":[]},{"propositions":[],"lastnames":["Fadlelmola"],"firstnames":["Faisal","M"],"suffixes":[]},{"propositions":[],"lastnames":["Fakim"],"firstnames":["Yasmina","J"],"suffixes":[]},{"propositions":[],"lastnames":["Hamdi"],"firstnames":["Yosr"],"suffixes":[]},{"propositions":[],"lastnames":["Kassim"],"firstnames":["Samar","Kamal"],"suffixes":[]},{"propositions":[],"lastnames":["Kumuthini"],"firstnames":["Judit"],"suffixes":[]},{"propositions":[],"lastnames":["Nembaware"],"firstnames":["Victoria"],"suffixes":[]},{"propositions":[],"lastnames":["Radouani"],"firstnames":["Fouzia"],"suffixes":[]},{"propositions":[],"lastnames":["Tiffin"],"firstnames":["Nicki"],"suffixes":[]},{"propositions":[],"lastnames":["Mulder"],"firstnames":["Nicola"],"suffixes":[]}],"doi":"10.3389/fgene.2022.769919","file":":C$\\$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Jongeneel et al. - 2022 - A view on genomic medicine activities in Africa implications for policy.pdf:pdf","issn":"1664-8021","journal":"Frontiers in Genetics","keywords":"Africa,OA,Personalized genomic medicine,Readiness level,Translational research,capacity development,fund_ack,infrastructure,original,precision medicine stakeholders","mendeley-tags":"OA,fund_ack,original","month":"apr","pages":"769919","pmid":"35571023","publisher":"Frontiers","title":"A view on genomic medicine activities in Africa: implications for policy","url":"https://www.frontiersin.org/articles/10.3389/fgene.2022.769919/full","volume":"13","year":"2022","bibtex":"@article{Jongeneel2022,\r\nabstract = {Genomics policy development involves assessing a wide range of issues extending from specimen collection and data sharing to whether and how to utilize advanced technologies in clinical practice and public health initiatives. A survey was conducted among African scientists and stakeholders with an interest in genomic medicine, seeking to evaluate: 1) Their knowledge and understanding of the field. 2) The institutional environment and infrastructure available to them. 3) The state and awareness of the field in their country. 4) Their perception of potential barriers to implementation of precision medicine. We discuss how the information gathered in the survey could instruct the policies of African institutions seeking to implement precision, and more specifically, genomic medicine approaches in their health care systems in the following areas: 1) Prioritization of infrastructures. 2) Need for translational research. 3) Information dissemination to potential users. 4) Training programs for specialized personnel. 5) Engaging political stakeholders and the public. A checklist with key requirements to assess readiness for implementation of genomic medicine programs is provided to guide the process from scientific discovery to clinical application.},\r\nauthor = {Jongeneel, C Victor and Kotze, Maritha J and Bhaw-Luximon, Archana and Fadlelmola, Faisal M and Fakim, Yasmina J and Hamdi, Yosr and Kassim, Samar Kamal and Kumuthini, Judit and Nembaware, Victoria and Radouani, Fouzia and Tiffin, Nicki and Mulder, Nicola},\r\ndoi = {10.3389/fgene.2022.769919},\r\nfile = {:C$\\backslash$:/Users/01462563/AppData/Local/Mendeley Ltd./Mendeley Desktop/Downloaded/Jongeneel et al. - 2022 - A view on genomic medicine activities in Africa implications for policy.pdf:pdf},\r\nissn = {1664-8021},\r\njournal = {Frontiers in Genetics},\r\nkeywords = {Africa,OA,Personalized genomic medicine,Readiness level,Translational research,capacity development,fund{\\_}ack,infrastructure,original,precision medicine stakeholders},\r\nmendeley-tags = {OA,fund{\\_}ack,original},\r\nmonth = {apr},\r\npages = {769919},\r\npmid = {35571023},\r\npublisher = {Frontiers},\r\ntitle = {{A view on genomic medicine activities in Africa: implications for policy}},\r\nurl = {https://www.frontiersin.org/articles/10.3389/fgene.2022.769919/full},\r\nvolume = {13},\r\nyear = {2022}\r\n}\r\n","author_short":["Jongeneel, C V.","Kotze, M. J","Bhaw-Luximon, A.","Fadlelmola, F. M","Fakim, Y. J","Hamdi, Y.","Kassim, S. K.","Kumuthini, J.","Nembaware, V.","Radouani, F.","Tiffin, N.","Mulder, N."],"key":"Jongeneel2022","id":"Jongeneel2022","bibbaseid":"jongeneel-kotze-bhawluximon-fadlelmola-fakim-hamdi-kassim-kumuthini-etal-aviewongenomicmedicineactivitiesinafricaimplicationsforpolicy-2022","role":"author","urls":{"Paper":"https://www.frontiersin.org/articles/10.3389/fgene.2022.769919/full"},"keyword":["Africa","OA","Personalized genomic medicine","Readiness level","Translational research","capacity development","fund_ack","infrastructure","original","precision medicine stakeholders"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://drive.google.com/uc?export=download&id=1-JLqZ7RwZ3VC2d6ErLGHAtOeMRS_7GCz","dataSources":["6GMFi5DCojy3jHY44","Krmt6gt9ktB2s6ARh"],"keywords":["africa","oa","personalized genomic medicine","readiness level","translational research","capacity development","fund_ack","infrastructure","original","precision medicine stakeholders"],"search_terms":["view","genomic","medicine","activities","africa","implications","policy","jongeneel","kotze","bhaw-luximon","fadlelmola","fakim","hamdi","kassim","kumuthini","nembaware","radouani","tiffin","mulder"],"title":"A view on genomic medicine activities in Africa: implications for policy","year":2022}